Press "Enter" to skip to content

Novartis wins Gilenya reprieve as judge blocks generics, for now

Novartis had asked for a preliminary injunction to halt generics makers including Dr. Reddy’s Laboratories, Mylan Pharmaceuticals, Torrent Pharma and Aurobindo Pharma, among others, from making or selling a Gilenya copy in the United States until a final decision on a Novartis patent for the medicine.

Original source: